Literature DB >> 12859666

Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies.

Amanda E Greene1, Mariana T Todorova, Thomas N Seyfried.   

Abstract

Brain cells are metabolically flexible because they can derive energy from both glucose and ketone bodies (acetoacetate and beta-hydroxybutyrate). Metabolic control theory applies principles of bioenergetics and genome flexibility to the management of complex phenotypic traits. Epilepsy is a complex brain disorder involving excessive, synchronous, abnormal electrical firing patterns of neurons. We propose that many epilepsies with varied etiologies may ultimately involve disruptions of brain energy homeostasis and are potentially manageable through principles of metabolic control theory. This control involves moderate shifts in the availability of brain energy metabolites (glucose and ketone bodies) that alter energy metabolism through glycolysis and the tricarboxylic acid cycle, respectively. These shifts produce adjustments in gene-linked metabolic networks that manage or control the seizure disorder despite the continued presence of the inherited or acquired factors responsible for the epilepsy. This hypothesis is supported by information on the management of seizures with diets including fasting, the ketogenic diet and caloric restriction. A better understanding of the compensatory genetic and neurochemical networks of brain energy metabolism may produce novel antiepileptic therapies that are more effective and biologically friendly than those currently available.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859666     DOI: 10.1046/j.1471-4159.2003.01862.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  43 in total

1.  Genetic analysis of biological pathway data through genomic randomization.

Authors:  Brian L Yaspan; William S Bush; Eric S Torstenson; Deqiong Ma; Margaret A Pericak-Vance; Marylyn D Ritchie; James S Sutcliffe; Jonathan L Haines
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  MRI estimation of global brain oxygen consumption rate.

Authors:  Varsha Jain; Michael C Langham; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

3.  Eating your way to seizure control.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Jul-Aug       Impact factor: 7.500

4.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

5.  Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.

Authors:  Carl E Stafstrom; Jeffrey C Ockuly; Lauren Murphree; Matthew T Valley; Avtar Roopra; Thomas P Sutula
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 6.  The ketogenic diet: proposed mechanisms of action.

Authors:  Kirk Nylen; Sergei Likhodii; W McIntyre Burnham
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 7.  Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Authors:  Susan A Masino; Jonathan D Geiger
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

Review 8.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

9.  Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats.

Authors:  David N Ruskin; Tracey A C S Suter; Jessica L Ross; Susan A Masino
Journal:  J Pain       Date:  2013-03-15       Impact factor: 5.820

Review 10.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.